- Stocks
- Healthcare
- NYSE: PKI

Price (delayed)

$137.20

Market cap

$15.36B

P/E Ratio

37.08

Dividend/share

$0.28

EPS

$3.7

Enterprise value

$17.13B

PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging,

Perkinelmer's net income has surged by 76% YoY and by 40% QoQ

The EPS has soared by 75% YoY and by 40% from the previous quarter

The quick ratio has increased by 6% QoQ but it has decreased by 2.3% YoY

The stock's price to earnings (P/E) is 4.5% more than its 5-year quarterly average of 35.5 but 2.9% less than its last 4 quarters average of 38.2

What are the main financial stats of PKI

Market
Valuations
Earnings

Shares outstanding

111.97M

Market cap

$15.36B

Enterprise value

$17.13B

Price to earnings (P/E)

37.08

Price to book (P/B)

4.75

Price to sales (P/S)

4.74

EV/EBIT

28.25

EV/EBITDA

20.25

EV/Sales

5.3

Revenue

$3.23B

EBIT

$606.58M

EBITDA

$846M

Free cash flow

$544.65M

Per share
Balance sheet
Liquidity

EPS

$3.7

Free cash flow per share

$4.88

Book value per share

$28.9

Revenue per share

$28.95

TBVPS

$22.58

Total assets

$6.87B

Total liabilities

$3.63B

Debt

$2.03B

Equity

$3.23B

Working capital

$431.02M

Debt to equity

0.63

Current ratio

1.35

Quick ratio

0.85

Net debt/EBITDA

2.09

Margins
Efficiency
Dividend

EBITDA margin

26.2%

Gross margin

52%

Net margin

12.7%

Operating margin

18.8%

Return on assets

6.2%

Return on equity

14%

Return on invested capital

18.7%

Return on capital employed

10.8%

Return on sales

18.8%

Dividend yield

0.2%

DPS

$0.28

Payout ratio

7.6%

How has the Perkinelmer stock price performed over time

Intraday

3.16%

1 week

7.97%

1 month

5.91%

1 year

47.69%

YTD

41.3%

QTD

9.31%

How have Perkinelmer's revenue and profit performed over time

Revenue

$3.23B

Gross profit

$1.68B

Operating income

$606.58M

Net income

$412.03M

Gross margin

52%

Net margin

12.7%

The company's operating income has surged by 79% YoY and by 39% QoQ

Perkinelmer's net income has surged by 76% YoY and by 40% QoQ

The company's operating margin has surged by 57% YoY and by 28% QoQ

PKI's net margin has soared by 53% year-on-year and by 28% since the previous quarter

What is Perkinelmer's growth rate over time

What is Perkinelmer stock price valuation

P/E

37.08

P/B

4.75

P/S

4.74

EV/EBIT

28.25

EV/EBITDA

20.25

EV/Sales

5.3

The EPS has soared by 75% YoY and by 40% from the previous quarter

The stock's price to earnings (P/E) is 4.5% more than its 5-year quarterly average of 35.5 but 2.9% less than its last 4 quarters average of 38.2

The price to book (P/B) is 44% higher than the 5-year quarterly average of 3.3 and 28% higher than the last 4 quarters average of 3.7

The equity is up by 19% year-on-year and by 9% since the previous quarter

The price to sales (P/S) is 44% higher than the 5-year quarterly average of 3.3 and 32% higher than the last 4 quarters average of 3.6

The company's revenue rose by 14% YoY and by 9% QoQ

How efficient is Perkinelmer business performance

PKI's return on invested capital has surged by 73% year-on-year and by 40% since the previous quarter

The company's return on assets has surged by 63% YoY and by 38% QoQ

PKI's return on equity has surged by 59% year-on-year and by 33% since the previous quarter

The ROS has soared by 57% YoY and by 28% from the previous quarter

What is PKI's dividend history

DPS

$0.28

Dividend yield

0.2%

Payout ratio

7.6%

Recent dividends

How did Perkinelmer financials performed over time

The total assets is 89% greater than the total liabilities

The quick ratio has increased by 6% QoQ but it has decreased by 2.3% YoY

The total assets has increased by 6% year-on-year and by 3.4% since the previous quarter

PKI's debt is 37% smaller than its equity

PKI's debt to equity is down by 29% year-on-year and by 13% since the previous quarter

The equity is up by 19% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.